Voyager V1

· Vyriad, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Voyager V1, covering 2025-03-26 to 2025-03-26. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients [Phase 2]